Oster G - Search Results

1

Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.

Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M. Fowler MB, et al. Among authors: oster g. J Am Coll Cardiol. 2001 May;37(6):1692-9. doi: 10.1016/s0735-1097(01)01190-1. J Am Coll Cardiol. 2001. PMID: 11345386 Free article.

2

Cost effectiveness of carvedilol for heart failure.

Delea TE, Vera-Llonch M, Richner RE, Fowler MB, Oster G. Delea TE, et al. Among authors: oster g. Am J Cardiol. 1999 Mar 15;83(6):890-6. doi: 10.1016/s0002-9149(98)01066-2. Am J Cardiol. 1999. PMID: 10190405

3

Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program.

Vera-Llonch M, Menzin J, Richner RE, Oster G. Vera-Llonch M, et al. Among authors: oster g. Ann Pharmacother. 2001 Jul-Aug;35(7-8):846-51. doi: 10.1345/aph.10114. Ann Pharmacother. 2001. PMID: 11485131 Clinical Trial.

4

Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.

Oster G, Huse DM, Lacey MJ, Regan MM, Fuchs HJ. Oster G, et al. Ann Pharmacother. 1995 May;29(5):459-64. doi: 10.1177/106002809502900501. Ann Pharmacother. 1995. PMID: 7655127 Clinical Trial.

5

Clinical and economic consequences of bleeding following major orthopedic surgery.

Vera-Llonch M, Hagiwara M, Oster G. Vera-Llonch M, et al. Among authors: oster g. Thromb Res. 2006;117(5):569-77. doi: 10.1016/j.thromres.2005.04.018. Thromb Res. 2006. PMID: 15913715

6

Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.

Menzin J, Huse DM, Richner R, Oster G. Menzin J, et al. Among authors: oster g. Pharmacoeconomics. 1992 Aug;2(2):171-7. doi: 10.2165/00019053-199202020-00009. Pharmacoeconomics. 1992. PMID: 10146956

7

Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.

Ollendorf DA, Vera-Llonch M, Oster G. Ollendorf DA, et al. Among authors: oster g. Am J Health Syst Pharm. 2002 Sep 15;59(18):1750-4. doi: 10.1093/ajhp/59.18.1750. Am J Health Syst Pharm. 2002. PMID: 12298113

8

Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.

Vera-Llonch M, Brandenburg NA, Oster G. Vera-Llonch M, et al. Among authors: oster g. Epilepsia. 2008 Mar;49(3):431-7. doi: 10.1111/j.1528-1167.2007.01279.x. Epub 2007 Sep 5. Epilepsia. 2008. PMID: 17822431 Free article.

9

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy.

Vera-Llonch M, Weycker D, Glass A, Gao S, Borker R, Barber B, Oster G. Vera-Llonch M, et al. Among authors: oster g. BMC Health Serv Res. 2011 Nov 10;11:305. doi: 10.1186/1472-6963-11-305. BMC Health Serv Res. 2011. PMID: 22074001 Free PMC article.

10

Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis.

Michaud K, Vera-Llonch M, Oster G. Michaud K, et al. Among authors: oster g. J Rheumatol. 2012 Jan;39(1):54-9. doi: 10.3899/jrheum.110491. Epub 2011 Nov 15. J Rheumatol. 2012. PMID: 22089466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters